• Market Capitalisation market-capitalisation-info ₹56,114 Cr
  • Price to Earnings Ratio price-to-earning 42.15
  • 12 Month Earnings monthly-earning ₹1,331 Cr

Lupin Ltd. Share Price

₹1,228.95

As on 11-Dec-2023 14:44 IST

up-down-arrow-10.40-0.84%

  • Prev Close info

    1,239.35

  • Day's Openinfo

    1,239.50

  • Today's Highinfo

    1,247.20

  • Today's Lowinfo

    1,224.05

  • Today's Volumeinfo

    5,05,541

  • 52 Week rangeinfo

    ₹628.00 - 1,308.95

Please wait...

Lupin Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Lupin
67.50 4.14 8.89 63.53 9.23 8.62 3.49
S&P BSE Sensex
14.99 7.79 5.04 12.51 15.03 14.88 12.65
S&P BSE Healthcare
31.15 4.52 6.82 29.21 12.68 17.57 12.19
As on 11-Dec-2023
2022
2021
2020
2019
2018
2017
2016
Lupin
-22.83 -5.01 26.67 -9.27 -4.41 -40.48 -19.42
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95
S&P BSE Healthcare
-12.10 20.87 61.45 -3.55 -5.89 0.49 -12.88

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Lupin Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Lupin Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Lupin Ltd.

        Other details of Lupin Ltd.

        Incorporated

        1983

        Chairman

        Manju D Gupta

        Managing Director

        Nilesh Gupta

        Group

        Lupin

        Headquarters

        Mumbai, Maharashtra

        FAQs for Lupin Ltd.

        The total asset value of Lupin Ltd. stood at ₹ 23,444 Cr as on 30-Sep-23

        The share price of Lupin Ltd. is ₹1,228.95 (NSE) and ₹1,229.50 (BSE) as of 11-Dec-2023 14:44 IST. Lupin Ltd. has given a return of 9.23% in the last 3 years.

        Lupin Ltd. has a market capitalisation of ₹ 56,114 Cr as on 11-Dec-2023. As per Value Research classification, it is a Large Cap company.

        The P/B ratio of Lupin Ltd. is 4.24 times as on 11-Dec-2023, a 0.29% premium to its peers’ median range of 3.28 times.

        The P/E ratio of Lupin Ltd. is 42.15 times as on 11-Dec-2023, a 0.4% premium to its peers’ median range of 30.01 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Lupin Ltd. and enter the required number of quantities and click on buy to purchase the shares of Lupin Ltd..

        Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilars; over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

        The promoter of Lupin Ltd. is Lupin Investments Pvt Ltd. Lupin Investments Pvt Ltd owns 45.52 per cent of the total equity. The chairman of the company is Manju D Gupta , and the managing director is Nilesh Gupta..

        The promoters of Lupin Ltd. have pledged 0% of the total equity as on Sep-23.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        2,96,438
        98,444
        97,728
        96,135
        Lupin Ltd. Ratios
        Return on equity(%)
        10.36
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0.32

        Yes, TTM profit after tax of Lupin Ltd. was ₹1,331 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information ₹56,114.30 Cr
        • Revenue (TTM)revenue-information ₹18,604.92 Cr
        • Earnings (TTM) earning-information ₹1,331.36 Cr
        • Cash date-information ₹1,732.89 Cr
        • Total Debt info ₹4,244.05 Cr
        • Promoters' ownership promoters_ownership 47.06%
        • Liquidity liquidity High
        • 52 Week range week-range ₹628.00 - 1,308.95
        • Face value face-value ₹2.00
        • Shares outstanding share-outstanding 45,52,88,458
        • 10 Years Aggregate:

          CFO: ₹17,440.41 Cr

          EBITDA: ₹27,366.59 Cr

          Net Profit: ₹9,690.29 Cr

        About The Company

        • Incorporated 1983
        • Chairman Manju D Gupta
        • Managing Director Nilesh Gupta
        • Group Lupin
        • Listing key-listing NSE: LUPIN
        • Country India
        • Headquarters headquarters Mumbai, Maharashtra
        • Website website www.lupin.com
        • Business

          Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in India and internationally. It offers formulations for...  use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. The company is also involved in the provision of biosimilars; over-the-counter products; specialty products; and drug discovery and development programs in the therapeutic areas of oncology, immunology, and metabolic disorders, as well as bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.